相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome A Secondary Analysis of the VISTA-16 Trial
Preethi Mani et al.
JAMA CARDIOLOGY (2019)
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aaron W. Aday et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Michael Lincoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
Stephen J. Nicholls et al.
AMERICAN HEART JOURNAL (2015)
Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality
Christina M. Parrinello et al.
AMERICAN HEART JOURNAL (2015)
C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy
Rishi Puri et al.
CIRCULATION (2013)
Long-term Assessment of Inflammation and Healthy Aging in Late Life: The Cardiovascular Health Study All Stars
Nancy S. Jenny et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)
Longitudinal Changes in Adiponectin and Inflammatory Markers and Relation to Survival in the Oldest Old: The Cardiovascular Health Study All Stars Study
Jorge R. Kizer et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality
C. J. Currie et al.
HEART (2008)
Three-year change in inflammatory markers in elderly people and mortality: The Invecchiare in Chianti study
Dawn E. Alley et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
PM Ridker
CIRCULATION (2003)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
